XML 113 R96.htm IDEA: XBRL DOCUMENT v3.25.4
STOCK-BASED COMPENSATION (Narrative) (Details)
 1 Months Ended 12 Months Ended
Apr. 29, 2024
USD ($)
employee
milestone
Feb. 24, 2024
USD ($)
milestone
Oct. 04, 2022
USD ($)
shares
Dec. 01, 2021
USD ($)
milestone
Feb. 29, 2024
USD ($)
milestone
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
milestone
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2016
tranche
$ / shares
Dec. 31, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period           3 years        
Granted (in shares) | shares           29,235,000        
Stock-based compensation expense           $ 9,525,000 $ 18,457,000 $ 23,504,000    
Other liabilities, noncurrent           24,000,000 25,001,000      
Aggregate intrinsic value           $ 0 $ 0 $ 0    
Stock options exercisable (in shares) | shares           0 0 0    
Unrecognized stock-based compensation expense           $ 0 $ 0 $ 0    
Stock based compensation expense reversal               $ 18,400,000    
Basic (in dollars per share) | $ / shares               $ 0.14    
Diluted (in dollars per share) | $ / shares               $ 0.14    
Volumetric Biotechnologies, Inc.                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense               $ (8,600,000)    
Additional payments $ 175,000,000.0     $ 355,000,000.0 $ 355,000,000.0          
Number of milestones | milestone       7            
Milestones terminated | milestone   4     4          
Reduced liability   $ 175,000,000.0     $ 175,000,000.0          
Remaining milestones | milestone 3 3     3          
Number of employees | employee 2                  
Earnout payment milestone               65,000,000.0    
Aggregate grant date fair value of outstanding and unvested               4,500,000    
Volumetric Biotechnologies, Inc. | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of milestones | milestone         4          
Volumetric Biotechnologies, Inc. | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of milestones | milestone         7          
Dp polar GmbH                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense             $ 1,000,000.0 $ 1,000,000.0    
Additional payments     $ 2,200,000              
Issuance of shares (in shares) | shares     250,000              
Issuance of shares to settle (in shares) | shares           250,000        
Systemic Bio Phantom Unit Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number (in shares) | shares             721,000 596,000    
Phantom Share Units (PSUs)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period           2 years 1 month 6 days        
Unrecognized stock-based compensation expense           $ 8,600,000        
Phantom Share Units (PSUs) | Systemic Bio Phantom Unit Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period               4 years    
Granted (in shares) | shares             147,000 597,000    
Stock-based compensation expense             $ 100,000 $ 500,000    
Other liabilities, noncurrent             $ 600,000 $ 500,000    
Unrecognized stock-based compensation expense           $ 600,000        
Restricted Stock - Market Conditions                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares awarded (in shares) | shares           1,687,753        
Restricted Stock Units (RSUs)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares) | shares           2,958,000 3,392,000 4,439,000    
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number (in shares) | shares           5,161,000 5,185,000 6,182,000   5,015,000
Granted (in dollars per share) | $ / shares           $ 2.25 $ 1.98 $ 10.26    
Stock Options and Restricted Stock Awards | 2015 Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of tranches | tranche                 2  
Trading price for stock award, tranche one (in dollars per share) | $ / shares                 $ 30  
Trading price for stock award, tranche two (in dollars per share) | $ / shares                 $ 40  
Stock award tranche granting period                 90 days  
Performance Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting period           3 years        
Granted (in shares) | shares           810,000        
Granted (in dollars per share) | $ / shares           $ 0.47        
Number of non-financial milestones | milestone             4      
Incentive Awards                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense           $ 0 $ 0 $ 0